Clinical Trial Update: Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants [Phase 1]

View source ↗

Summary

Phase 1 study of an investigational multicomponent meningococcal group B vaccine given alone or with other licensed vaccines in adults, adolescents, toddlers, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Meningococcal Disease

Drugs mentioned

• Investigational multicomponent meningococcal group B vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Immunisation, Healthy Volunteers | Phase 1 | Status: TERMINATED